Alpha Family Trust Makes New $215,000 Investment in Cigna Group $CI

Alpha Family Trust acquired a new position in shares of Cigna Group (NYSE:CI) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 655 shares of the health services provider’s stock, valued at approximately $215,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Evermay Wealth Management LLC raised its position in shares of Cigna Group by 58.6% during the 1st quarter. Evermay Wealth Management LLC now owns 111 shares of the health services provider’s stock valued at $37,000 after acquiring an additional 41 shares during the last quarter. Richardson Financial Services Inc. bought a new stake in shares of Cigna Group during the 1st quarter valued at $38,000. Wayfinding Financial LLC bought a new stake in shares of Cigna Group during the 1st quarter valued at $40,000. Putney Financial Group LLC bought a new stake in shares of Cigna Group during the 4th quarter valued at $36,000. Finally, Transce3nd LLC bought a new stake in shares of Cigna Group during the 4th quarter valued at $38,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

CI stock opened at $297.02 on Monday. The stock has a 50-day moving average price of $302.03 and a two-hundred day moving average price of $311.33. The stock has a market cap of $79.28 billion, a PE ratio of 16.21, a price-to-earnings-growth ratio of 0.87 and a beta of 0.47. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 1 year low of $256.89 and a 1 year high of $370.83.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%. The firm had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. During the same quarter in the prior year, the company earned $6.72 EPS. The company’s revenue was up 11.0% on a year-over-year basis. Equities analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group’s dividend payout ratio is currently 32.97%.

Analysts Set New Price Targets

Several analysts have commented on the stock. Wells Fargo & Company dropped their target price on shares of Cigna Group from $341.00 to $340.00 and set an “equal weight” rating for the company in a research report on Thursday. Royal Bank Of Canada reiterated an “outperform” rating and set a $371.00 target price on shares of Cigna Group in a research report on Thursday, June 26th. Morgan Stanley upped their price objective on shares of Cigna Group from $379.00 to $390.00 and gave the company an “overweight” rating in a research report on Monday, May 5th. Barclays lowered their price objective on shares of Cigna Group from $385.00 to $354.00 and set an “overweight” rating for the company in a research report on Friday, August 1st. Finally, Cowen restated a “buy” rating on shares of Cigna Group in a research report on Monday, May 5th. Three investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $378.33.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.